Revmoxicam (meloxicam) rectal suppositories 0.015 g. N5


Short- term symptomatic treatment of acute attacks of rheumatoid arthritis and ankylosing spondylitis, when oral and rectal routes of administration can not be applied.



Composition and form of release
The active ingredient is meloxicam.
Release form – rectal suppositories (suppositories).
One suppository Revmoxicam contains 15 mg of meloxicam.

Pharmacological properties
Non-steroidal anti-inflammatory (NSAID) and antirheumatic agent.
It has analgesic, anti-inflammatory and antipyretic effects.

Suppositories Revmoxicam are used for the symptomatic treatment of pain syndrome with:

  • ankylosing spondylitis;
  • osteoarthritis;
  • rheumatoid arthritis.

Suppositories Revmoxicam are prohibited in case of hypersensitivity to them or to other NSAIDs.

Also contraindications to the use of Revmoxicam are:

  • the presence of ulcers / perforation in the digestive tract;
  • blood clotting disorders, bleeding;
  • severe liver failure;
  • active Crohn’s disease / ulcerative colitis;
  • severe renal failure without dialysis;
  • past rectal bleeding or proctitis;
  • severe uncontrolled heart failure.

Application during pregnancy and lactation
Suppositories Revmoxicam are contraindicated in women during the above periods.

Method of administration and dosage
For osteoarthritis, rheumatoid arthritis and ankylosing spondylitis, the drug Revmoxicam is used one suppository (fifteen milligrams) per day.
The maximum recommended dose of this pharmaceutical preparation is one suppository / day.
With the combined use of different forms of pharmaceuticals Revmoxicam, the total daily dose should not exceed fifteen milligrams.

For acute drug overdose Revmoxicam is characterized by: drowsiness, abdominal pain, nausea, lethargy, vomiting. Bleeding from the digestive tract is also possible. In severe poisoning, hypertension, liver dysfunction, acute renal failure, cardiac arrest, coma may occur.
Treatment for an overdose with suppositories Revmoxicam involves discontinuing the drug, performing rectal lavage and conducting symptomatic treatment. There is no specific antidote.

Side effects
Side effects that may occur during the use of suppositories Revmoxicam include the following: stomatitis, dizziness, dyspepsia, palpitations, esophagitis, flatulence, headache, swelling, tinnitus, drowsiness, mood changes, conjunctivitis, confusion, visual disturbances, nausea, colitis, increased blood pressure, hot flashes, gastritis, disorientation, gastroduodenal ulcer, acute renal failure, vomiting, photosensitivity, liver dysfunction, abdominal pain, pruritus, belching, gastrointestinal perforation, constipation / diarrhea, skin rashes, bleeding from the digestive tract.
Changes in the blood picture may also occur – thrombocytopenia (a decrease in the number of platelets), leukopenia (a decrease in the number of white blood cells), anemia (a decrease in the number of red blood cells).
Possible anaphylactic reactions, polymorphic erythema, Stevens-Johnson syndrome, angioedema, urticaria.
Patients who are allergic to NSAIDs may develop an asthma attack.
Local side effects against the background of the use of suppositories Revmoxicam include edema, itching or burning in the anorectal region.

Storage conditions and periods
Store candles Revmoxicam at temperatures below + 25 ° C.
The shelf life of suppositories is two years.